Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024
-
ESE Entertainment Completes 100% Acquisition of Gaming Production Company, Bombee Americas
-
Deep Origin Launches First and Only Drug Discovery Assistant with Conversational AI Interface and Top Docking Technology
-
Hospitality Training Institute of Michigan celebrates more than 730 graduates this year and launches 2025 course registration
-
Renault and Cerence Partner to Bring Generative AI to Reno, the Renault Connected Avatar
-
American Rebel Light Beer Expands Distribution Network to the Commonwealth of Kentucky with Clark Distributing Company
-
Alliance Entertainment Inks Exclusive Partnership with Magenta Light Studios
-
Brooklyn Law School Reinforces Commitment to Veteran Students with Increased Scholarship Support
-
GDEV Announces Leadership Transition
-
Abits Group Inc. Announces Operational Updates for The Third Quarter Ended September 30, 2024
-
Cox Media Group Announces Early Tender Results and Amendment of the Exchange Offer and Consent Solicitation for its 8.875% Senior Notes due 2027
-
A Family’s Race To Treat Childhood Blindness: A Race Against Blindness Grants $1 Million to Bardet-Biedl Syndrome Research
-
Glass House Brands to Host Third Quarter 2024 Conference Call on November 13, 2024
-
DiagnaMed Advancing the Medical Potential of Hydrogen
-
Four in Five Recent Home Buyers May Look to Refinance in the Next 12 Months to Help Alleviate Strain on Personal Finances
-
Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra™ in Patients with Osteoarthritis
-
NANO Nuclear Energy Closes Full Over-Allotment Option Raising Total Funds of Over $40 Million From Recent Underwritten Follow-On Offering
-
IQST - iQSTEL to Present at the AI & Technology Virtual Investor Conference October 31st
-
Noema Pharma Announces First Patients Dosed in Phase 2b Study with Gemlapodect (NOE-105), a First-In-Class Investigational Therapy for Tourette Syndrome
-
Armstrong International Secures Funding from European Commission’s Innovation Fund to Support Factory Expansion in Herstal, Belgium
-
Spectral AI Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers
-
LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024
-
NUMERATOR ANNOUNCES 200,000 PANEL WITH NEW TRANSPARENCY STANDARD
-
ASP Isotopes Inc. to Present at the Emerging Growth Conference on Wednesday, October 30, 2024
-
ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference
-
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
-
Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company
-
Kalsec Publishes “Beyond the Burn” Survey Findings, Highlighting Consumer Preferences for Spicy Foods
-
Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024
-
LaunchDarkly Launches Dedicated EU Region to Support EU Data Residency and Compliance Needs
-
Brera Holdings Provides Update on Women’s Football Club Brera Tiverija’s Outstanding Season
-
Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference
-
PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024
-
MOOG® Unveils New Constant Velocity Axles
-
Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024
-
Numab Therapeutics Announces Initiation of Phase 1 Clinical Study of NM32 Program in Patients with Solid Tumors
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Director/PDMR Shareholding
-
Industry Leader Clearlight® Honors Service with Exclusive Veterans Day Offer
-
Jeffs' Brands Enters Into a Non-Binding Letter of Intent for the Sale of its U.S. Subsidiary to a U.S. Public Company, at a valuation of approximately $13.125 million
-
Jeffs' Brands Enters Into a Non-Binding Letter of Intent for the Sale of its U.S. Subsidiary to a U.S. Public Company, at a valuation of approximately $13.125 million
-
Mattr to Present and Host 1x1 Investor Meetings at the 16th Annual Southwest Ideas Investor Conference on November 20th in Dallas, TX
-
Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
-
TC Energy lists Series 10 Preferred Shares
-
InspireSemi Announces Annual General and Special Meeting and Appointment of Director
-
Midland Identifies Copper-Gold-Molybdenum-Silver Occurrences on the Saruman Project
-
Amerigo Announces Q3-2024 Results & Quarterly Dividend
-
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update
-
Stock Yards Bancorp to Participate in the 2024 Hovde Group Financial Services Conference
-
MariMed Commences Manufacturing Operations in Missouri

